Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Pluronic F-68

Base Information Edit
  • Chemical Name:Pluronic F-68
  • CAS No.:53637-25-5
  • Molecular Formula:C5H10O2
  • Molecular Weight:266.33
  • Hs Code.:
  • European Community (EC) Number:618-355-0,923-642-1
  • NSC Number:63908
  • NCI Thesaurus Code:C178536,C2211,C80936,C84069,C84070,C84071
  • RXCUI:155152,155155,1314414,1486516
  • Metabolomics Workbench ID:152643
  • Mol file:53637-25-5.mol
Pluronic F-68

Synonyms:Bloat Guard;Oxyethylene Oxypropylene Polymer;Oxypropylene Polymer, Oxyethylene;Poloxalene;Poloxalene 2930;Polymer, Oxyethylene Oxypropylene;Polyoxyethylene Polyoxypropylene Polyoxyethylene Polymer;Proxanol;SK and F 18667;SK and F-18667;SK and F18667;Tergitol;Therabloat

Suppliers and Price of Pluronic F-68
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • American Custom Chemicals Corporation
  • ETHYLENE GLYCOL BIS(PROPYLENE GLYCOL-BETA-ETHYLENE GLYCOL)ETHER 95.00%
  • 5MG
  • $ 497.42
Total 47 raw suppliers
Chemical Property of Pluronic F-68 Edit
Chemical Property:
  • Melting Point:?32 °C(lit.) 
  • Refractive Index:n20/D 1.453(lit.)  
  • Boiling Point:32.9 °C at 760 mmHg 
  • Flash Point:55.2 °C 
  • PSA:77.38000 
  • Density:1.017 g/mL at 25 °C(lit.) 
  • LogP:-0.18560 
  • Hydrogen Bond Donor Count:0
  • Hydrogen Bond Acceptor Count:2
  • Rotatable Bond Count:0
  • Exact Mass:102.068079557
  • Heavy Atom Count:7
  • Complexity:36.7
Purity/Quality:

99% *data from raw suppliers

ETHYLENE GLYCOL BIS(PROPYLENE GLYCOL-BETA-ETHYLENE GLYCOL)ETHER 95.00% *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Chemical Classes:Plastics & Rubber -> Polymers
  • Canonical SMILES:CC1CO1.C1CO1
  • Recent ClinicalTrials:Topical Umbilical Cord Care for the Prevention of Colonization and Invasive Infections
  • Recent EU Clinical Trials:Evaluation of MST-188 in Acute Lower Limb Ischemia: A Phase 2 Randomized Double-Blind, Placebo-Controlled, Multi-Center Clinical Trial Evaluating the Safety and Efficacy Of MST-188 in Subjects with Acute Lower Limb Ischemia Receiving Catheter-Directed Recombinant Tissue Plasminogen Activator
Post RFQ for Price